Breaking News Instant updates and real-time market news.

SNPS

Synopsys

$126.00

-0.74 (-0.58%)

09:03
06/14/19
06/14
09:03
06/14/19
09:03

Synopsys replenishes stock repurchase authorization to $500M

Synopsys announced that its Board of Directors has replenished its existing stock repurchase authorization to $500M. Synopsys' Board of Directors originally approved the stock repurchase program in 2002 and has periodically replenished the program as funds are spent. The program does not obligate Synopsys to acquire any particular amount of common stock, and the program may be suspended or terminated at any time at Synopsys' discretion.

  • 09

    Jul

  • 16

    Jul

  • 17

    Jul

  • 26

    Sep

  • 27

    Sep

SNPS Synopsys
$126.00

-0.74 (-0.58%)

04/10/19
KEYB
04/10/19
INITIATION
Target $135
KEYB
Overweight
Synopsys resumed with an Overweight at KeyBanc
KeyBanc analyst Jason Celino resumed coverage of Synopsys with an Overweight rating and $135 price target. The analyst cited its EDA tailwinds, potential margin leverage, and underappreciated software integrity business. The analyst believes the company could be on a $4B run rate exiting 2021, and with 28% operating margins and a 16% tax rate, he could see over $6.15 in EPS.
04/11/19
RBCM
04/11/19
NO CHANGE
Target $140
RBCM
Top Pick
Synopsys price target raised to $140 from $130 at RBC Capital
RBC Capital analyst Mitch Steves raised his price target for Synopsys to $140 from $130 as upside case increases. After taking a more detailed look through the Synopsys Analyst Day deck, the analyst thinks the upside case for the company now stands at $6.50 EPS and that the stock could be worth about $175 in a more bullish scenario. Additionally, he has increased conviction in margin expansion due to the rising costs of SoC design, and thinks the software integrity business will remain profitable. The analyst reiterates a Top Pick rating on the shares.
05/14/19
WELS
05/14/19
INITIATION
WELS
Outperform
Synopsys initiated with an Outperform at Wells Fargo
05/14/19
WELS
05/14/19
INITIATION
Target $150
WELS
Outperform
Synopsys initiated with an Outperform at Wells Fargo
Wells Fargo analyst Gary Mobley started Synopsys with an Outperform rating and $150 price target. The company offers a "secure, defensible way" to invest in the long-term growth of the semiconductor and electronics systems industries, Mobley tells investors in a research note. The analyst likes the competitive dynamics in the electronic design automation market.

TODAY'S FREE FLY STORIES

BA

Boeing

$375.05

5.68 (1.54%)

08:02
06/27/19
06/27
08:02
06/27/19
08:02
Recommendations
Boeing analyst commentary  »

BofA continues to see 6-9…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 24

    Jul

CABO

Cable One

$1,111.46

-18.95 (-1.68%)

08:02
06/27/19
06/27
08:02
06/27/19
08:02
Recommendations
Cable One analyst commentary  »

Cable One price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VFC

VF Corp.

$85.74

0.32 (0.37%)

08:01
06/27/19
06/27
08:01
06/27/19
08:01
Recommendations
VF Corp. analyst commentary  »

VF Corp. price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

TSLA

Tesla

$219.22

-0.47 (-0.21%)

08:00
06/27/19
06/27
08:00
06/27/19
08:00
Options
Tesla put buyer realizes 36% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COUP

Coupa Software

$119.01

-1.3 (-1.08%)

07:57
06/27/19
06/27
07:57
06/27/19
07:57
Recommendations
Coupa Software analyst commentary  »

Coupa Software price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jul

BB

BlackBerry

$7.55

-0.74 (-8.93%)

07:56
06/27/19
06/27
07:56
06/27/19
07:56
Recommendations
BlackBerry analyst commentary  »

BlackBerry execution…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SM

SM Energy

$12.56

0.63 (5.28%)

07:55
06/27/19
06/27
07:55
06/27/19
07:55
Initiation
SM Energy initiated  »

SM Energy initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

07:55
06/27/19
06/27
07:55
06/27/19
07:55
General news
Oil Action: WTI crude »

Oil Action: WTI crude…

ITRI

Itron

$60.88

0.48 (0.79%)

07:55
06/27/19
06/27
07:55
06/27/19
07:55
Conference/Events
Itron to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

XEC

Cimarex Energy

$57.17

1.64 (2.95%)

07:53
06/27/19
06/27
07:53
06/27/19
07:53
Initiation
Cimarex Energy initiated  »

Cimarex Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

COUP

Coupa Software

$119.01

-1.3 (-1.08%)

07:52
06/27/19
06/27
07:52
06/27/19
07:52
Recommendations
Coupa Software analyst commentary  »

Coupa Software price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jul

LECO

Lincoln Electric

$79.77

0.1 (0.13%)

07:52
06/27/19
06/27
07:52
06/27/19
07:52
Downgrade
Lincoln Electric rating change  »

Lincoln Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EV

Eaton Vance

$42.13

0.455 (1.09%)

07:50
06/27/19
06/27
07:50
06/27/19
07:50
Conference/Events
Eaton Vance to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LBC

Luther Burbank

$10.33

-0.13 (-1.24%)

07:50
06/27/19
06/27
07:50
06/27/19
07:50
Upgrade
Luther Burbank rating change at Sandler ONeill »

Luther Burbank upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QIWI

Qiwi

$20.29

0.54 (2.73%)

07:49
06/27/19
06/27
07:49
06/27/19
07:49
Hot Stocks
Qiwi appoints Vladislav Poshmorga as CFO »

QIWI announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KBH

KB Home

$23.58

-0.24 (-1.01%)

07:48
06/27/19
06/27
07:48
06/27/19
07:48
Upgrade
KB Home rating change  »

KB Home upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIZZ

National Beverage

$42.28

-0.92 (-2.13%)

07:47
06/27/19
06/27
07:47
06/27/19
07:47
Recommendations
National Beverage analyst commentary  »

Guggenheim says National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIVE

Aerohive

$4.44

1.26 (39.62%)

07:46
06/27/19
06/27
07:46
06/27/19
07:46
Downgrade
Aerohive rating change at Craig-Hallum »

Aerohive downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMGN

ImmunoGen

$1.95

0.14 (7.73%)

07:45
06/27/19
06/27
07:45
06/27/19
07:45
Conference/Events
ImmunoGen to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

ACRS

Aclaris Therapeutics

$4.45

0.06 (1.37%)

07:43
06/27/19
06/27
07:43
06/27/19
07:43
Downgrade
Aclaris Therapeutics rating change at SVB Leerink »

Aclaris Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APLS

Apellis

$23.45

-0.38 (-1.59%)

07:43
06/27/19
06/27
07:43
06/27/19
07:43
Hot Stocks
Apellis complete enrollment of Phase 3 APL-2 head-to-head study »

Apellis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

TRIP

TripAdvisor

$44.04

-0.47 (-1.06%)

07:41
06/27/19
06/27
07:41
06/27/19
07:41
Upgrade
TripAdvisor rating change  »

TripAdvisor upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRIM

Primoris

$19.95

0.44 (2.26%)

07:40
06/27/19
06/27
07:40
06/27/19
07:40
Hot Stocks
Primoris announces industrial awards valued over $69M »

Primoris Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KBH

KB Home

$23.58

-0.24 (-1.01%)

07:39
06/27/19
06/27
07:39
06/27/19
07:39
Upgrade
KB Home rating change  »

KB Home upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OPGN

OpGen

$0.40

-0.0123 (-2.95%)

07:39
06/27/19
06/27
07:39
06/27/19
07:39
Hot Stocks
OpGen says Acuitas panel shows potential to reduce total time to therapy »

OpGen announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.